Structure |
Chemical Name |
CAS |
MF |
 |
Peramivir Amino Carboxylic Isomerism Impurity |
|
|
 |
Peramivir Chlorinated Impurity |
|
|
 |
Brivaracetam Impurity 999 |
|
|
 |
Dasatinib impurity 48 |
|
|
 |
Pemetrexed Impurity 120 |
|
|
 |
Ticagrelor Impurity 101 |
|
|
![4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane](/) |
4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane |
|
|
 |
1-(3-((2,4-dimethylphenyl)thio)phenyl)piperazine hydrochloride |
2137793-92-9 |
|
 |
(R)-(-)-2-AMINOBUTANAMIDE HYDROCHLORIDE, 97% |
103765-03-3 |
C4H11ClN2O |
 |
Flomoxef Impurity 20 Sodium Salt |
2095697-77-9 |
C15H18F2N6O7S2 |
 |
((2R,3S,4R)-3,4,5-trihydroxytetrahydrofuran-2-yl)methyl isobutyrate |
2591381-21-2 |
C9H16O6 |
amino]-5-(4-nitrophenyl)-, ethyl ester](/CAS/20210305/GIF/2591260-07-8.gif) |
3-Thiophenecarboxylic acid, 4-(bromomethyl)-2-[[(2,6-difluorophenyl)methyl](propoxycarbonyl)amino]-5-(4-nitrophenyl)-, ethyl ester |
2591260-07-8 |
C25H23BrF2N2O6S |
![Cyclohexanecarboxylic acid, 2-[[[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]amino]carbonyl]-, (1R,2S)-rel-](/CAS/20210305/GIF/190582-37-7.gif) |
Cyclohexanecarboxylic acid, 2-[[[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]amino]carbonyl]-, (1R,2S)-rel- |
190582-37-7 |
C23H32N4O3S |
 |
Ivabradine Impurity II |
|
|
![(1R,2R,4S,5S,7r)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate](/CAS/20211123/GIF/792155-94-3.gif) |
(1R,2R,4S,5S,7r)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate |
792155-94-3 |
C18H19NO4S2 |
 |
Tafluprost Impurity 17 |
|
|
 |
Labetalol EP impurity E |
|
|
 |
1-Propanol, 3-(2-methoxy-5-nitrophenoxy)- |
1156068-41-5 |
C10H13NO5 |
 |
1616710-52-1 |
1616710-52-1 |
C27H34N2O6 |
 |
6-ヒドロキシオンダンセトロン |
110708-17-3 |
C18H19N3O2 |
![8-クロロ-5,6-ジヒドロ-11H-ベンゾ[5,6]シクロヘプタ[1,2-b]ピリジン-11-オン](/CAS/GIF/31251-41-9.gif) |
8-クロロ-5,6-ジヒドロ-11H-ベンゾ[5,6]シクロヘプタ[1,2-b]ピリジン-11-オン |
31251-41-9 |
C14H10ClNO |
 |
(R)-Ornidazole |
166734-80-1 |
C7H10ClN3O3 |
 |
Bendamustine Related Impurity 22 |
|
|
 |
Bendamustine Related Impurity 9 |
|
|
 |
Edoxaban Impurity 40 |
2081883-52-3 |
C14H27N3O3 |
 |
Everolimus Impurity 2 |
|
|
 |
Levosimendan Impurity 2 (Mixture ofZandEIsomers) |
|
|
 |
Solifenacin Related Compound 29 |
861998-77-8 |
C23H26N2O3 |
 |
Ticagrelor Impurity 31 |
|
|
 |
Ticagrelor Related Compound 46 |
2205903-73-5 |
C28H42ClN9O8S2 |
 |
Ticagrelor Related Compound 71 |
1548397-10-9 |
C7H8ClN3O3S |
 |
Ticagrelor Related Compound 76 |
|
|
 |
Vonoprazan Impurity 25 |
|
|
 |
Blonanserin Impurity M |
|
|
 |
Brexpiprazole Impurity H |
|
|
 |
Cefaclor EP Impurity H |
|
|
 |
Flupentixol Impurity B |
|
|
 |
Ipratropium Bromide Impurity J |
|
C20H29Br2NO3 |
 |
Cefdinir impurity TU mixture |
|
|
![1-[(2'-Cyano[1,1'-biphenyl]-4-yl)MethylaMino]-N-pentanoylcyclopentanecarboxaMide](/CAS/GIF/141745-71-3.gif) |
1-[(2'-Cyano[1,1'-biphenyl]-4-yl)MethylaMino]-N-pentanoylcyclopentanecarboxaMide |
141745-71-3 |
C25H29N3O2 |
 |
PF 2825 |
153012-65-8 |
C21H28N2O5S |
![3,3'-[Dithiobis[(2S,4S)-4,2-pyrrolidinediylcarbonyliMino]]bisbenzoic Acid Dihydrochloride](/CAS/GIF/444057-64-1.gif) |
3,3'-[Dithiobis[(2S,4S)-4,2-pyrrolidinediylcarbonyliMino]]bisbenzoic Acid Dihydrochloride |
444057-64-1 |
C24H27ClN4O6S2 |
 |
エルタペネム二量體型D不純物 |
1199797-41-5 |
C44H50N6O14S2 |
 |
S 00218 |
92700-82-8 |
C15H22N2O4 |
 |
Loratadine IMpurity D |
|
C22H23ClN2O2 |
 |
PeMetrexed EP IMpurity A |
869791-42-4 |
C21H23N5O6 |
 |
Itraconazole EP IMpurity G |
|
|
 |
(1R,2S)-2-(3,4-ジフルオロフェニル)シクロプロパンアミン塩酸塩 |
1402222-66-5 |
C9H10ClF2N |
 |
IMp. E (EP): 1,4-Bis(diphenylMethyl)piperazine |
216581-01-0 |
C30H30N2 |
 |
21-デヒドロ-6α-メチルプレドニソロン |
58636-50-3 |
C22H28O5 |
 |
α-Hydroxy Flurbiprofen |
61466-95-3 |
C15H13FO3 |
 |
9-AcridinaMine, 6-chloro-2-ethoxy- |
855939-48-9 |
C15H13ClN2O |
![1-(6-メチルピリジン-3-イル)-2-[4-(メチルチオ)フェニル]エタノン](/CAS/20150408/GIF/221615-72-1.gif) |
1-(6-メチルピリジン-3-イル)-2-[4-(メチルチオ)フェニル]エタノン |
221615-72-1 |
C15H15NOS |
 |
Edaravone |
68195-63-1 |
C30H26N6O3 |
 |
Erlotinib IMpurity C |
1312937-41-9 |
C15H20N2O5 |
![(R)-N-[1-(5,6,7,8-テトラヒドロナフタレン-1-イル)エチル]-3-[3-(トリフルオロメチル)フェニル]-1-プロピルアミン](/CAS/20150408/GIF/1229224-93-4.gif) |
(R)-N-[1-(5,6,7,8-テトラヒドロナフタレン-1-イル)エチル]-3-[3-(トリフルオロメチル)フェニル]-1-プロピルアミン |
1229224-93-4 |
C22H26F3N |
 |
SalMeterol iMpurity |
144391-74-2 |
C25H37NO4 |
 |
ceftazidiMe iMpurity E |
|
|
 |
セフロキシムアキセチル不純物C (85%) |
76598-06-6 |
C18H15Cl3N4O9S |
 |
Rupatadine iMpurity D |
|
|
 |
2-(2-fluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-3-(4H-1,2,4-triazol-4-yl)propan-2-ol |
|
C13H13FN6O |
 |
Dapagliflozin Impurity 10 |
960404-86-8 |
C21H25ClO7 |
 |
Ibrutinib Impurity 6 |
1917333-91-5 |
C28H26N6O3 |
 |
Imatinib Impurity 5 |
|
|
 |
Mirabegron Impurity 8 HCl |
1684452-81-0 |
C21H24N4O2S |
 |
Regorafenib Impurity 2 |
|
|
 |
Vonoprazan Impurity 5 |
|
|
 |
Bendamustine |
1219709-86-0 |
C14H18ClN3O2 |
 |
Dapagliflozin Impurity E |
|
|
 |
Febuxostat Impurity 14 |
1335202-60-2 |
C15H16N2OS |
 |
2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one |
1367369-77-4 |
C12H15N5O3 |
 |
Carfilzomib Impurity B |
|
|
 |
Ornidazole Impurity 1 |
1100750-18-2 |
|
 |
Ornidazole Impurity |
1100750-18-2 |
|
 |
4-(3-nitrophenyl)-3-Morpholinone |
845729-43-3 |
C10H10N2O4 |
 |
1,3-bis(2-chloroethyl)benzimidazolin-2-one |
55470-74-1 |
C11H12Cl2N2O |
 |
Nintedanib Impurity A (Intedanib Impurity A ) |
|
|
 |
Tigecycline Impurity 6 |
|
|
 |
Febuxostat Bromo Impurity |
144060-40-2 |
C15H16BrNO3S |
 |
Meptazinol Impurity |
1314003-47-8 |
C23H28N2O4 |
 |
1'H-2,3'-bipyridinyl-2'-one |
101002-01-1 |
C10H8N2O |
 |
Brexpiprazole Impurity D |
|
|
 |
Brivaracetam Impurity E |
|
|
 |
Dapoxetine Impurity 8 |
|
|
 |
Irbesartan Impurity 6 |
|
C25H28N6O |
![6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine](/CAS/20180703/GIF/1812890-23-5.gif) |
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine |
1812890-23-5 |
C13H21N5 |
 |
Sacubitril Impurity 72 |
1361408-16-3 |
C23H27NO4 |
 |
Clemastine |
108825-05-4 |
C21H26ClNO2 |
 |
4-chloro-7-methoxyquinoline-6-carboxylic acid |
771464-30-3 |
C11H8ClNO3 |
![ethyl (41S,13aR)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20210111/GIF/85647-43-4.gif) |
ethyl (41S,13aR)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
85647-43-4 |
C22H26N2O2 |
![methyl (41R,12R,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20210111/GIF/38990-16-8.gif) |
methyl (41R,12R,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
38990-16-8 |
C21H26N2O3 |
 |
Dolutegravir Impurity 3 |
1973402-05-9 |
C20H19F2N3O5 |
 |
Cistracurium Besylate EP Impurity D |
1075726-88-3 |
C31H39NO9S |
![(R)-1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-chloropropan-1-one](/CAS/20180703/GIF/1288338-96-4.gif) |
(R)-1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-chloropropan-1-one |
1288338-96-4 |
C25H25ClN6O2 |
 |
Bendamustine Impurity 8 |
1797881-48-1 |
C14H19Cl2N3O2 |
 |
FeBuxostat Impurity 32 |
1805770-41-5 |
C12H12N2O |
 |
Edoxaban Impurity 9(1R,2S,4S) |
2024614-15-9 |
C21H30ClN5O5 |
 |
Rivaroxaban Impurity 22 |
1350288-77-5 |
C19H18ClN3O5S |
 |
Rivaroxaban Impurity 27 |
1369969-44-7 |
C21H21N3O5 |
 |
Gliclazide Impurity A |
|
|